Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 45/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
  • Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
  • Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
  • Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
  • Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
  • Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
Find Similar Products

Basic Info.

Model NO.
Ponazuril
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>98%
Color
White Crystalline Powder
Density
1.32
Molecular Formula
C18h14f3n3o6s
Formula Weight
334.39
CAS
61-33-6
Storage Condition
Seal and Store in a Cool, Dry Place
Transport Package
Aluminium Foil Bag and Carton
Specification
98% Ponazuril
Trademark
HNB
Origin
China
HS Code
2934999022
Production Capacity
25 Mt/Month

Product Description

Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril
Manufacturer Supply Veterinary API CAS 53716-50-0 Oxfendazole powder
 

Name  :      Ponazuril
Shape :      White crystalline powder

Use for :   

            (1) Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis in horses, caused by Sarcocystis neurona.

           (2) Ponazuril have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.



Tolterazuril sulfone (Ponazuril) is a metabolite of Tolterazuril (HY-B0175), which has anti protozoan activity. Toltrazuril sulfone is a triazine based anticoccidial agent developed for the prevention of coccidiosis in poultry.

                 
             
Ponazuril is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona. More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.

               

Name CAS molecular density
Ponazuril 61-33-6 C18h14f3n3o6s 1.32
 
Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril           Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril

 

 

 

 

Manufacturer Supply Veterinary API CAS 61-33-6 PonazurilManufacturer Supply Veterinary API CAS 61-33-6 Ponazuril

Manufacturer Supply Veterinary API CAS 61-33-6 Ponazuril

Manufacturer Supply Veterinary API CAS 61-33-6 PonazurilManufacturer Supply Veterinary API CAS 61-33-6 PonazurilManufacturer Supply Veterinary API CAS 61-33-6 PonazurilManufacturer Supply Veterinary API CAS 61-33-6 Ponazuril

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier